ID   CLK3_HUMAN              Reviewed;         638 AA.
AC   P49761; Q53Y48; Q9BRS3; Q9BUJ7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 3.
DT   05-OCT-2010, entry version 110.
DE   RecName: Full=Dual specificity protein kinase CLK3;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 3;
GN   Name=CLK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   MEDLINE=95082033; PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 137-638 (ISOFORM 4).
RC   TISSUE=Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9637771; DOI=10.1006/excr.1998.4083;
RA   Duncan P.I., Stojdl D.F., Marius R.M., Scheit K.H., Bell J.C.;
RT   "The Clk2 and Clk3 dual-specificity protein kinases regulate the
RT   intranuclear distribution of SR proteins and influence pre-mRNA
RT   splicing.";
RL   Exp. Cell Res. 241:300-308(1998).
RN   [6]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-155; SER-197; SER-199;
RP   SER-224 AND SER-226, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-155; SER-157; SER-215;
RP   SER-224; SER-226 AND SER-283, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-155; SER-157; SER-224
RP   AND SER-226, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 284-638.
RA   Papagrigoriou E., Rellos P., Das S., Ugochukwu E., Turnbull A.,
RA   von Delft F., Bunkoczi G., Sobott F., Bullock A., Fedorov O.,
RA   Gileadi C., Savitsky P., Edwards A., Aerrowsmith C., Weigel J.,
RA   Sundstrom M., Knapp S.;
RT   "Crystal structure of CLK3.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 275-627.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the phosphorylated clk3.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-486; ARG-607 AND TRP-628.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates serine- and arginine-rich (SR) proteins
CC       of the spliceosomal complex. May be a constituent of a network of
CC       regulatory mechanisms that enable SR proteins to control RNA
CC       splicing. Phosphorylates serines, threonines and tyrosines.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm (By similarity).
CC       Cytoplasmic vesicle, secretory vesicle, acrosome (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=4;
CC         IsoId=P49761-4; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49761-1; Sequence=VSP_026138;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49761-2; Sequence=VSP_026138, VSP_004858, VSP_004859;
CC         Note=Lacks the kinase domain. May be produced at very low levels
CC         due to a premature stop codon in the mRNA, leading to
CC         nonsense-mediated mRNA decay;
CC       Name=3;
CC         IsoId=P49761-3; Sequence=VSP_026138, VSP_004860;
CC   -!- PTM: Autophosphorylates on all three types of residues (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. Lammer subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02555.1; Type=Erroneous initiation;
CC       Sequence=AAH19881.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L29220; AAA61483.1; -; mRNA.
DR   EMBL; L29217; AAA61484.1; -; mRNA.
DR   EMBL; BT006993; AAP35639.1; -; mRNA.
DR   EMBL; AC100835; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002555; AAH02555.1; ALT_INIT; mRNA.
DR   EMBL; BC006103; AAH06103.1; -; mRNA.
DR   EMBL; BC019881; AAH19881.1; ALT_INIT; mRNA.
DR   IPI; IPI00219340; -.
DR   IPI; IPI00219341; -.
DR   IPI; IPI00298896; -.
DR   IPI; IPI00847415; -.
DR   PIR; S53639; S53639.
DR   PIR; S53640; S53640.
DR   RefSeq; NP_001123500.1; -.
DR   RefSeq; NP_003983.2; -.
DR   UniGene; Hs.584748; -.
DR   PDB; 2EU9; X-ray; 1.53 A; A=284-638.
DR   PDB; 2EXE; X-ray; 2.35 A; A=275-631.
DR   PDB; 2WU6; X-ray; 1.92 A; A=275-632.
DR   PDB; 2WU7; X-ray; 2.25 A; A=275-632.
DR   PDBsum; 2EU9; -.
DR   PDBsum; 2EXE; -.
DR   PDBsum; 2WU6; -.
DR   PDBsum; 2WU7; -.
DR   ProteinModelPortal; P49761; -.
DR   IntAct; P49761; 5.
DR   MINT; MINT-1448658; -.
DR   STRING; P49761; -.
DR   PhosphoSite; P49761; -.
DR   Ensembl; ENST00000454830; ENSP00000391518; ENSG00000179335.
DR   GeneID; 1198; -.
DR   KEGG; hsa:1198; -.
DR   UCSC; uc002ayg.2; human.
DR   UCSC; uc002ayj.2; human.
DR   CTD; 1198; -.
DR   GeneCards; GC15P074900; -.
DR   HGNC; HGNC:2071; CLK3.
DR   MIM; 602990; gene.
DR   PharmGKB; PA26597; -.
DR   eggNOG; prNOG05054; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG107720; -.
DR   OrthoDB; EOG9X3KM2; -.
DR   BRENDA; 2.7.12.1; 247.
DR   NextBio; 4949; -.
DR   ArrayExpress; P49761; -.
DR   Bgee; P49761; -.
DR   CleanEx; HS_CLK3; -.
DR   Genevestigator; P49761; -.
DR   GermOnline; ENSG00000179335; Homo sapiens.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    638       Dual specificity protein kinase CLK3.
FT                                /FTId=PRO_0000085870.
FT   DOMAIN      304    620       Protein kinase.
FT   NP_BIND     310    318       ATP (By similarity).
FT   COMPBIAS    167    264       Arg-rich.
FT   ACT_SITE    431    431       Proton acceptor (By similarity).
FT   BINDING     334    334       ATP (By similarity).
FT   MOD_RES     155    155       Phosphotyrosine.
FT   MOD_RES     157    157       Phosphoserine.
FT   MOD_RES     197    197       Phosphoserine.
FT   MOD_RES     199    199       Phosphoserine.
FT   MOD_RES     215    215       Phosphoserine.
FT   MOD_RES     224    224       Phosphoserine.
FT   MOD_RES     226    226       Phosphoserine.
FT   MOD_RES     283    283       Phosphoserine.
FT   VAR_SEQ       1    148       Missing (in isoform 1, isoform 2 and
FT                                isoform 3).
FT                                /FTId=VSP_026138.
FT   VAR_SEQ     272    300       RSQQSSKRSSRSVEDDKEGHLVCRIGDWL -> MRLWGTWV
FT                                KAPLARWWSAWTMPEGSLRLP (in isoform 2).
FT                                /FTId=VSP_004858.
FT   VAR_SEQ     301    638       Missing (in isoform 2).
FT                                /FTId=VSP_004859.
FT   VAR_SEQ     306    328       Missing (in isoform 3).
FT                                /FTId=VSP_004860.
FT   VARIANT     486    486       R -> C.
FT                                /FTId=VAR_040413.
FT   VARIANT     607    607       Q -> R.
FT                                /FTId=VAR_045579.
FT   VARIANT     628    628       R -> W.
FT                                /FTId=VAR_045580.
FT   CONFLICT    280    281       SS -> TG (in Ref. 1; AAA61484).
FT   TURN        301    303
FT   STRAND      304    313
FT   STRAND      316    323
FT   TURN        324    328
FT   STRAND      330    336
FT   HELIX       340    359
FT   STRAND      370    376
FT   STRAND      379    385
FT   HELIX       391    397
FT   TURN        398    400
FT   HELIX       405    423
FT   TURN        424    426
FT   HELIX       434    436
FT   STRAND      437    440
FT   STRAND      444    448
FT   STRAND      456    460
FT   STRAND      464    466
FT   HELIX       486    488
FT   HELIX       491    494
FT   HELIX       502    517
FT   HELIX       527    538
FT   HELIX       543    548
FT   HELIX       552    554
FT   HELIX       567    575
FT   HELIX       579    582
FT   HELIX       588    600
FT   TURN        605    607
FT   HELIX       611    614
FT   HELIX       618    622
FT   HELIX       625    628
SQ   SEQUENCE   638 AA;  73515 MW;  D3B60A9DB4ECEC94 CRC64;
     MPVLSARRRE LADHAGSGRR SGPSPTARSG PHLSALRAQP ARAAHLSGRG TYVRRDTAGG
     GPGQARPLGP PGTSLLGRGA RRSGEGWCPG AFESGARAAR PPSRVEPRLA TAASREGAGL
     PRAEVAAGSG RGARSGEWGL AAAGAWETMH HCKRYRSPEP DPYLSYRWKR RRSYSREHEG
     RLRYPSRREP PPRRSRSRSH DRLPYQRRYR ERRDSDTYRC EERSPSFGED YYGPSRSRHR
     RRSRERGPYR TRKHAHHCHK RRTRSCSSAS SRSQQSSKRS SRSVEDDKEG HLVCRIGDWL
     QERYEIVGNL GEGTFGKVVE CLDHARGKSQ VALKIIRNVG KYREAARLEI NVLKKIKEKD
     KENKFLCVLM SDWFNFHGHM CIAFELLGKN TFEFLKENNF QPYPLPHVRH MAYQLCHALR
     FLHENQLTHT DLKPENILFV NSEFETLYNE HKSCEEKSVK NTSIRVADFG SATFDHEHHT
     TIVATRHYRP PEVILELGWA QPCDVWSIGC ILFEYYRGFT LFQTHENREH LVMMEKILGP
     IPSHMIHRTR KQKYFYKGGL VWDENSSDGR YVKENCKPLK SYMLQDSLEH VQLFDLMRRM
     LEFDPAQRIT LAEALLHPFF AGLTPEERSF HTSRNPSR
//
